Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VARIVAX PE34 Process vs Commercial Process in Children
NCT03239873Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2017
- Primary completion
- Aug 2018
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by Merck & Co.. Started Oct 2017; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT03239873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03239873.